Lv3
206 积分 2023-09-27 加入
A portrait of germline mutation in Brazilian at-risk for hereditary breast cancer
6天前
已完结
The rediscovery of platinum-based cancer therapy
21天前
已完结
Targeting PI3K in Cancer Treatment: A Comprehensive Review with Insights from Clinical Outcomes
27天前
已完结
PI3K/AKT/mTOR inhibitors for hormone receptor-positive advanced breast cancer
27天前
已完结
A therapeutic algorithm guiding subsequent therapy selection after CDK4/6 inhibitors’ failure: a review of current and investigational treatment for HR+/Her2- breast cancer
27天前
已完结
Germline Mutations in Cancer Susceptibility Genes in a Large Series of Unselected Breast Cancer Patients
28天前
已完结
Neoadjuvant chemotherapy with or without anthracyclines in the presence of dual HER2 blockade for HER2-positive breast cancer (TRAIN-2): a multicentre, open-label, randomised, phase 3 trial
29天前
已完结
Timing of nivolumab with neoadjuvant carboplatin and paclitaxel for early triple-negative breast cancer (BCT1902/IBCSG 61–20; Neo-N): a non-comparative, open-label, randomised, phase 2 trial
29天前
已关闭
AI model using clinical images for genomic prediction and tailored treatment in patients with cancer
29天前
已完结
Tailoring chemoimmunotherapy de-escalation in early-stage triple-negative breast cancer
29天前
已关闭
皖公网安备34019202002308
